SIM
IPXL

Strategic Investment Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Strategic Investment Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,982
Closed -$316K – 142
2014
Q4 		$316K Buy
+9,982
New +$292K 0.09% 42

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Strategic Investment Management's IPXL Position: Q1 2015 in Review

Strategic Investment Management sold out of Impax Laboratories, Inc. (IPXL) in Q1 2015, closing a stake of 9,982 shares — an estimated $316K sold.

Strategic Investment Management first reported a position in IPXL in Q4 2014 and held it in 1 quarter. The position peaked at $316K in Q4 2014. 197 funds tracked by Wall St. Rank hold IPXL as of Q1 2015.

  • Strategic Investment Management reported no remaining Impax Laboratories, Inc. position as of Q1 2015 after selling out during the quarter.
  • Strategic Investment Management sold 9,982 Impax Laboratories, Inc. shares in Q1 2015, an estimated $316K.
  • Strategic Investment Management first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 1 quarter.
  • Strategic Investment Management's Impax Laboratories, Inc. position peaked at $316K in Q4 2014.
  • 197 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2015.

Based on Strategic Investment Management's 13F filing for Q1 2015, filed 14 May 2015.